Publications for Leslie Citrome nntman@gmail.com
Cooper, A., Ferro, A., Lloyd, G., O'Kane, P., Waring, E., & Citrome, L. (2016). In memoriam: Dr Graham Jackson, 1947-2016. International Journal of Clinical Practice, 70(8), 638-639. doi:10.1111/ijcp.12864
Correll, C. U., Citrome, L., Haddad, P. M., Lauriello, J., Olfson, M., Calloway, S. M., & Kane, J. M. (2016). The use of long-acting injectable antipsychotics in schizophrenia: Evaluating the evidence. The Journal of Clinical Psychiatry, 77(suppl 3), 1-24. doi:10.4088/JCP.15032su1
Durgam, S., Chen, C., Gommoll, C. P., Edwards, J., & Citrome, L. (2016). Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: Post hoc analysis of four randomized, placebo-controlled trials. Neuropsychiatric Disease and Treatment, 12, 3073-3081. doi:10.2147/NDT.S117581
Garay, R. P., Citrome, L., Grossberg, G. T., Cavero, I., & Llorca, P. M. (2016). Investigational drugs for treating agitation in persons with dementia. Expert Opinion on Investigational Drugs, 25(8), 973-983. doi:10.1080/13543784.2016.1193155
Garay, R. P., Citrome, L., Samalin, L., Liu, C. C., Thomsen, M. S., Correll, C. U., . . . Llorca, P. M. (2016). Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: An appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries. Expert Opinion on Pharmacotherapy, 17(7), 921-936. doi:10.1517/14656566.2016.1149164
Kim, H., Kim, W., Citrome, L., Akiskal, H. S., Goffin, K. C., Miller, S., . . . Ketter, T. A. (2016). More inclusive bipolar mixed depression definition by permitting overlapping and non-overlapping mood elevation symptoms. Acta Psychiatrica Scandinavica, 134(3), 199-206. doi:10.1111/acps.12580
Kim, W., Kim, H., Citrome, L., Akiskal, H. S., Goffin, K. C., Miller, S., . . . Ketter, T. A. (2016). More inclusive bipolar mixed depression definitions by requiring fewer non-overlapping mood elevation symptoms. Acta Psychiatrica Scandinavica, 134(3), 189-198. doi:10.1111/acps.12563
Lineberry, N., Berlin, J. A., Mansi, B., Glasser, S., Berkwits, M., Klem, C., . . . Citrome, L. (2016). Recommendations to improve adverse event reporting in clinical trial publications: A joint pharmaceutical industry/journal editor perspective. BMJ, 355, i5078. doi:10.1136/bmj.i5078
Loebel, A., Silva, R., Goldman, R., Watabe, K., Cucchiaro, J., Citrome, L., & Kane, J. M. (2016). Lurasidone dose escalation in early nonresponding patients with schizophrenia: A randomized, placebo-controlled study. The Journal of Clinical Psychiatry, 77(12), 1672-1680. doi:10.4088/JCP.16m10698
MacEwan, J. P., Seabury, S., Aigbogun, M. S., Kamat, S., van Eijndhoven, E., Francois, C., . . . Citrome, L. (2016). Pharmaceutical innovation in the treatment of schizophrenia and mental disorders compared with other diseases. Innovations in Clinical Neuroscience, 13(7-8), 17-25. This material can be found here.
Aquila, R., & Citrome, L. (2015). Cognitive impairment in schizophrenia: The great unmet need. CNS Spectrums, 20(Suppl 1), 32-40. doi:10.1017/S109285291500070X
Battisti, W. P., Wager, E., Baltzer, L., Bridges, D., Cairns, A., Carswell, C. I., . . . Citrome, L. (2015). Good publication practice for communicating company-sponsored medical research: GPP3. Annals of Internal Medicine, 163(6), 461-464. doi:10.7326/M15-0288
Citrome, L. (2015). A primer on binge eating disorder diagnosis and management. CNS Spectrums, 20(Suppl 1), 44-50; quiz 51. doi:10.1017/S1092852915000772
Citrome, L. (2015). Access to the biomedical literature: Beyond the paywall. International Journal of Clinical Practice, 69(10) [Article 1031]. doi:10.1111/ijcp.12743
Citrome, L. (2015). An evidence-based medicine field guide to new and current psychotropic medications and related drugs: A virtual issue of the International Journal of Clinical Practice. International Journal of Clinical Practice, 69(12), 1393-1395. doi:10.1111/ijcp.12755
Citrome, L. (2015). Brexpiprazole: A new dopamine D2receptor partial agonist for the treatment of schizophrenia and major depressive disorder. Drugs of Today, 51(7), 397-414. doi:10.1358/dot.2015.51.7.2358605
Citrome, L. (2015). Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: A systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International Journal of Clinical Practice, 69(9), 978-997. doi:10.1111/ijcp.12714
Citrome, L. (2015). Brexpiprazole for schizophrenia and as adjunct for major depressive disorder. Current Psychiatry, 14(10), 73-78. DOI:10.1111/ijcp.12714
Citrome, L. (2015). Conflicts of interest: A matter of transparency. International Journal of Clinical Practice, 69(3), 267-268. doi:10.1111/ijcp.12638
Citrome, L. (2015). Lisdexamfetamine for binge eating disorder in adults: A systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International Journal of Clinical Practice, 69(4), 410-421. doi:10.1111/ijcp.12639
Citrome, L. (2015). Medical photography: It has never been so easy and yet so complex. International Journal of Clinical Practice, 69(4) [Article 387]. doi:10.1111/ijcp.12647
Citrome, L. (2015). Moving forward with article level metrics: Introducing altmetrics. International Journal of Clinical Practice, 69(8) [Article 811]. doi:10.1111/ijcp.12706
Citrome, L. (2015). My two favourite professional social networking sites: LinkedIn and ResearchGate - how they can help you, or hurt you. International Journal of Clinical Practice, 69(6), 623-624. doi:10.1111/ijcp.12681
Citrome, L. (2015). Partial and non-adherence: We need all the help we can get. International Journal of Clinical Practice, 69(1), 1-2. doi:10.1111/ijcp.12610
Citrome, L. (2015). The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 69(11), 1211-1220. doi:10.1111/ijcp.12752
